Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Dunne Michael W. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Exercised 1,779 options to buy @ $0
06/15/2023 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Exercised 15,853 options to buy @ $0
04/03/2023 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Exercised 1,299 options to buy @ $0
02/27/2023 4/A Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
01/04/2023 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Exercised 761 options to buy @ $0
12/28/2022 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Granted 3,487 options to buy @ $0
09/27/2022 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Granted 1,779 options to buy @ $0
09/09/2022 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Bought 10,000 shares @ $2.22, valued at $22.2k
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2022 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Exercised 10,494 options to buy @ $0
Granted 11,426 options to buy @ $0
07/27/2021 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Granted 80,000 shares @ $0
06/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2021 4 Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc
Txns: Granted 80,000 shares @ $0
Sold 33,143 shares @ $1.73, valued at $57.3k
10/28/2020 4 Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc
Txns: Bought 61,540 shares @ $0
Bought 46,155 warrants @ $0.65, valued at $30k
02/19/2019 4 Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc
Txns: Granted 85,000 options to buy @ $5.8, valued at $493k
09/06/2018 4 Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc
Txns: Bought 500 shares @ $10, valued at $5k
08/28/2018 4 Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc
Txns: Bought 500 shares @ $10, valued at $5k
Bought 500 shares @ $10, valued at $5k
05/30/2018 4 Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc
Txns: Converted 12,730 shares @ $0
Converted 4,050 shares @ $0
Converted 2,917 shares @ $0
Bought 2,000 shares @ $13, valued at $26k
Converted 12,730 options to buy @ $0
Converted 4,050 options to buy @ $0
Converted 2,917 options to buy @ $0
05/29/2018 4 Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc
Txns: Granted 79,567 options to buy @ $13, valued at $1M
05/24/2018 3 Dunne Michael W. (Chief Scientific Officer) has filed a Form 3 on Iterum Therapeutics plc
05/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2016 4 Dunne Michael W. (Director) has filed a Form 4 on Aviragen Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $1.5, valued at $30k
10/21/2015 4 Dunne Michael W. (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc.
Txns: Granted 35,000 options to buy @ $1.95, valued at $68.3k
11/18/2014 4 Dunne Michael W. (Chief Medical Officer) has filed a Form 4 on Durata Therapeutics, Inc.
Txns: Disposed/sold 13,220 shares @ $0
Disposed/sold 281,250 options to buy @ $0.96, valued at $270k
Disposed/sold 18,850 options to buy @ $10, valued at $188.5k
Disposed/sold 12,500 options to buy @ $10, valued at $125k
Disposed/sold 50,000 options to buy @ $7.49, valued at $374.5k
Disposed/sold 100,000 options to buy @ $16.15, valued at $1.6M
05/22/2014 4 Dunne Michael W. (Chief Medical Officer) has filed a Form 4 on Durata Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $16.15, valued at $1.6M
02/14/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
07/26/2012 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy